SELVITA
Selvita has two primary focus areas: to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services, and as a drug discovery company engaged in the research and development of breakthrough therapies in oncology. The company was established in 2007 and currently employs over 360 scientists, among which 30% are PhDs.
SELVITA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Sedziszow Malopolski, Podkarpackie, Poland
Country:
Poland
Website Url:
http://www.selvita.com
Total Employee:
501+
Status:
Active
Contact:
+48 12 297 47 00
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Glycodiag
Glycodiag is an R&D firm that gains valuable experience in leading a wide variety of projects in the area of glycobiology & glycoanalysis.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-03-31 | BioCentrum | BioCentrum acquired by Selvita | N/A |
Newest Events participated
Participated in Science: Polish Perspectives
on 2015-10-30 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-19 | Selvita appoints Dean Bornilla as Vice President of Sales, Head of North America |
Official Site Inspections
http://www.selvita.com Semrush global rank: 3.59 M Semrush visits lastest month: 4.02 K
- Host name: 104.21.7.222
- IP address: 104.21.7.222
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Selvita"
Leader In Preclinical Contract Research - Selvita
Bogusลaw Sieczkowski is the Chief Executive Officer and co-founder of Selvita, holds over 25 years of experience in building leading high-tech organizations. โฆSee details»
Selvita - Crunchbase Company Profile & Funding
Selvita has two primary focus areas: to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services, โฆSee details»
Say HI to the new Selvita - Selvita
Evolution is important. It makes things better, stronger and more adapted to the reality around us. A year ago Selvita has acquired Fidelta, a 200-people contract research organization with core โฆSee details»
Selvita - LinkedIn
Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug ...See details»
Selvita Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Selvita has 4 employees across 5 locations and zล351.85 m in annual revenue in FY 2023. See insights on Selvita including office locations, competitors, revenue, financials, โฆSee details»
Selvita is a preclinical Contract Research Organization
Strategies For Navigating the Triple Threat: Partnerships, Innovation, and Compliance 26 - 27 March, 2025 | BerlinSee details»
Selvita (WSE:SLV) Company Profile & Description - Stock Analysis
Mar 21, 2025 Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug โฆSee details»
Selvita S.A. | LSOS Collaboration Platform
In addition, Selvita is an international contract research organization that provides world-class pharmaceutical services in drug testing and bioanalytical analysis. We perform services at โฆSee details»
Selvita - Overview, News & Similar companies | ZoomInfo.com
View Selvita (www.selvita.com) location in Lesser Poland Voivodeship, Poland , revenue, industry and description. Find related and similar companies as well as employees by title and much โฆSee details»
We are Selvita. Together we transform science into discoveries.
Krakow, Poland โ January 19, 2023 โ we recently celebrated the 15th anniversary of Selvita as a company and a brand. These have been fantastic but challenging years when we worked hard โฆSee details»
Selvita heads towards new development phase. Corporate and โฆ
Feb 1, 2022 Selvita is a preclinical Contract Research Organization providing multidisciplinary support in resolving the unique challenges of research within area of drug discovery, โฆSee details»
Selvita S.A. at the Swiss Biotech Day
Selvita is a preclinical Contract Research Organization providing multidisciplinary support in resolving the unique challenges of research within the areas of drug discovery and drug โฆSee details»
Selvita | Digital Health Corporate Profiles | HealthTech Alpha
Selvita We have grown from a 20-people start-up to a global organization, yet we still focus on the same goal: to become a true partner for our Clients, providing multidisciplinary support in their โฆSee details»
Selvita strengthens management structure in sales and drug โฆ
Dec 10, 2024 Selvita reports growing sales in Q2 and Q3, and projects increased profitability in H2 2024 . Selvita S.A. (WSE: SLV), one of the leading preclinical contract research โฆSee details»
Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog โฆ
3 days ago Big Pharma now represents 26% of Selvita's revenue, reinforcing the Group's foundation with long-term contracts. The backlog for 2025 stands at EUR 51 million 4 , โฆSee details»
Breakthrough year in the development of Selvita โ strategic โฆ
Selvitaโs subsidiary Ardigen S.A. โ reported dynamic development with a 69% y/y increase in revenues from its clients amounting to EUR 4.0 million The Companyโs EBITDA result and net โฆSee details»
Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog โฆ
4 days ago A video conference to discuss Selvitaโs 2024 results will be held on March 27 at 11:00 a.m. The event will be livestreamed at live.selvita.com. Bogusลaw Sieczkowski, co โฆSee details»
Selvita with record results in 2022, builds a base for further โฆ
KRAKOW, Poland, March 30, 2023 /PRNewswire/ -- Selvita S.A. [WSE: SLV] โ one of the largest CRO (Contract Research Organization) companies in Europe has published a full-year report โฆSee details»
Selvita strengthens management structure in sales and drug โฆ
Selvita is bolstering its international sales structure with the hiring of Dr. Paul Overton as Chief Commercial Officer. Bringing over 25 years of expertise in the pharmaceutical, biotechnology โฆSee details»
Selvita sums up 2021 and announces Development Strategy for โฆ
Selvita aims at an over threefold increase in revenues in 2025, compared to 2021, while maintaining high profitability. Krakow, March 31, 2022 โ Selvita S.A. โ [ticker: WSE: SLV] โ โฆSee details»